Hematopoietic stem cell transplantation can be a life-saving treatment for people with blood cancer. But some people are too old or weak to withstand the harsh “conditioning” regimen necessary to kill the diseased cells before transplantation. Some are also more likely to experience serious complications like graft-versus-host disease, or GVHD. This is especially true of older patients or those with underlying health conditions. However, age alone does not provide accurate or reliable enough information about an individual’s ability to withstand transplantation.
At Fred Hutch, researchers have developed risk-assessment tools to better predict survival after hematopoietic cell transplants for patients with acute myeloid leukemia, or AML. The tool helps doctors and patients refine decision-making about the modality and intensity of therapy for AML patients. Our current research aims at assessing the best treatment options to increase quality of life for older and more infirm patients with AML.
Under the mentorship of the Staff Scientist and Project Coordinator, the Clinical Research Intern will assist with tasks throughout the entire research process, including:
Please note that internships are unpaid six month positions requiring at least 10 hours per week.